Literature DB >> 27921380

Induction of labour for suspected macrosomia at term in non-diabetic women: a systematic review and meta-analysis of randomized controlled trials.

E R Magro-Malosso1, G Saccone2, M Chen3, R Navathe3, M Di Tommaso1, V Berghella3.   

Abstract

BACKGROUND: Several randomized controlled trials (RCTs) compared induction of labour with expectant management in non-diabetic women with suspected fetal macrosomia.
OBJECTIVE: To evaluate the effects of labour induction for suspected fetal macrosomia. SEARCH STRATEGY: Literature search in electronic databases. SELECTION CRITERIA: We included all RCTs of suspected fetal macrosomia comparing labour induction with expectant management in term pregnancy. DATA COLLECTION AND ANALYSIS: The primary outcome was the incidence of caesarean delivery. MAIN
RESULTS: Four RCTs, including 1190 non-diabetic women with suspected fetal macrosomia at term, were analysed. Pooled data did not show a significant difference in incidence of caesarean delivery [relative risk (RR) 0.91, 95% confidence interval (CI) 0.76-1.09], operative and spontaneous vaginal delivery, shoulder dystocia, intracranial haemorrhage, brachial plexus palsy, Apgar score <7 at 5 min, cord blood pH <7, and mean birth weight comparing women who received induction of labour with those who were managed expectantly. The induction group had a significantly lower time to delivery (mean difference -7.55 days, 95% CI -8.20 to -6.89), lower rate of birth weight ≥4000 g (RR 0.50, 95% CI 0.42-0.59) and ≥4500 g (RR 0.21, 95% CI 0.11-0.39), and lower incidence of fetal fractures (RR 0.17, 95% CI 0.03-0.79) compared with expectant management group.
CONCLUSION: Induction of labour ≥38 weeks for suspected fetal macrosomia is associated with a significant decrease in fetal fractures, and therefore can be considered as a reasonable option. TWEETABLE ABSTRACT: #Induction of labour for #macrosomia improves neonatal outcome.
© 2016 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Caesarean; expectant management; induction; macrosomia; non-diabetic; shoulder dystocia

Mesh:

Year:  2016        PMID: 27921380     DOI: 10.1111/1471-0528.14435

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  6 in total

1.  Protocol for the prospective observational clinical study: estimation of fetal weight by MRI to PREdict neonatal MACROsomia (PREMACRO study) and small-for-gestational age neonates.

Authors:  Caroline Kadji; Mieke M Cannie; Andrew Carlin; Jacques C Jani
Journal:  BMJ Open       Date:  2019-03-27       Impact factor: 2.692

2.  Intracervical Foley Catheter Plus Intravaginal Misoprostol vs Intravaginal Misoprostol Alone for Cervical Ripening: A Meta-Analysis.

Authors:  Howard Hao Lee; Ben-Shian Huang; Min Cheng; Chang-Ching Yeh; I-Chia Lin; Huann-Cheng Horng; Hsin-Yi Huang; Wen-Ling Lee; Peng-Hui Wang
Journal:  Int J Environ Res Public Health       Date:  2020-03-11       Impact factor: 3.390

3.  A systematic scoping review of clinical indications for induction of labour.

Authors:  Dominiek Coates; Angela Makris; Christine Catling; Amanda Henry; Vanessa Scarf; Nicole Watts; Deborah Fox; Purshaiyna Thirukumar; Vincent Wong; Hamish Russell; Caroline Homer
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

4.  Non-diabetic fetal macrosomia: outcomes of elective delivery versus expectant management.

Authors:  Gillian A Corbett; Samuel Hunter; Amina Javaid; Emma McNamee; Michael O'Connell; Stephen W Lindow; Aisling Martin
Journal:  Ir J Med Sci       Date:  2022-07-04       Impact factor: 2.089

Review 5.  A Systematic Review to Compare Adverse Pregnancy Outcomes in Women with Pregestational Diabetes and Gestational Diabetes.

Authors:  Nompumelelo Malaza; Matladi Masete; Sumaiya Adam; Stephanie Dias; Thembeka Nyawo; Carmen Pheiffer
Journal:  Int J Environ Res Public Health       Date:  2022-08-31       Impact factor: 4.614

6.  External validation and clinical usefulness of first-trimester prediction models for small- and large-for-gestational-age infants: a prospective cohort study.

Authors:  Lje Meertens; Ljm Smits; Smj van Kuijk; R Aardenburg; Ima van Dooren; J Langenveld; I M Zwaan; Mea Spaanderman; Hcj Scheepers
Journal:  BJOG       Date:  2019-01-17       Impact factor: 6.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.